This is a sure way to become a pathfinder. It is simply to find a path that others will follow. But to find a path has many things that come along with it. You will need to think and talk differently, especially like a person that can find a path. Have you heard of the story of the men that built America? These were the captains of industries and inventors that brought America’s civilization.

Since then great people have become pathfinders in many ways in our days. Here are some of the men that are spearheading the revolutions of the 21st century.

1. Microsoft Inc that was founded by Bill Gates and Paul Allen in 1975 became the pathfinder of the Software industry. The company is contently worth over $1trn market cap according to NASDAQ.
2. Amazon.com Inc. The company was founded by Jeff Bezos in 1994 and became the pathfinder of the e-commerce industry. The company is currently worth over $1tn market cap according to NASDAQ
3. Uber Inc. The company was founded in 2008 by Travis Kalanick and Garrett Camp. This became the pathfinder of the sharing industry. Uber has a market cap of $69.9bn according to NYSE

These great men became pathfinders because they founded a path.

Now coming to Africa, who are our pathfinders? What path are they finding that will indeed declare that they are pathfinders. Indeed, to build the Africa of our dream we need entrepreneurs that will become pathfinders.

Today Sasai App is not just an African technological milestone but has become an Africa digital pathfinder. I will open your eyes to the uncommon pathways that Sasai is helping to find in African economy.

How is Sasai App an African Digital Pathfinder

For a company or an entrepreneur to be a pathfinder that means he should do what has not been done before. That is the unique and special features of the pathfinders above. Here are what Sasai App is doing that are uncommon in Africa digital space;

 Ecosystem of Businesses:

The word ecosystem simply means an environment or a community that supports the existence of  different things. Sasai has employed the power of digital technology to house some of the major businesses of the world. This makes the Sasai mobile app an ecosystem for various businesses. When you get to the explore section of the App, you will see businesses by industries categorisation, such as Music, Gaming, Sports, Travels, News and Media, TV & Radio, Well Being, Ride-hailing, Food, Delivery, E-shop, E-market, E-service and finances. We have many businesses under each industry. Download, install, Visit and explore here.

 The super App Factor:

A super app is a kind of mobile application that gives you the ability to do many activities on the same platform. On sasai you can chat, you can make payment(Including remit), you can explore whatever you want. So, it literally combines the features and functions of famous platforms such as Youtube, Whatsapp, Paypal,Uber.

 Spearheading African language Digitization:

The digital divide is a very great problem for Africa in this digital age. Digital divide simply means exclusion from participation on the internet or the digital world. One such area that Africa is experiencing the divide is the lack of digitisation of african languages. According to UNESCO, about 43% of the world’s 6000  languages are now considered endangered. African languages are facing the chances of extinction in the future. That means the less people speak and use these languages, the more they will become forgotten and obsolete.

So, Sasai App has translated and digitised most of the african languages in order to solve the problem of extinctions, bridging digital divide and also to create economic value for those that can not speak English or French. We currently have Yoruba, Shona,Igbo, Swahili etc, more than 20 African languages digitised on the sasai app.

Spearheading African Content Digitization:

In order to solve the problem of the digital divide in Africa and also digitise and preserve our languages we need to also translate and digitise African contents.

So Sasai had developed innovation in order to speed up the digitalisation of every African content. The innovation includes; Sasai Watch, Sasai Watch Live, Sasai Podcast, Sasai moments etc. We can now have African books translated into podcasts in African language. We have local artists and influencers digitise their contents and upload  them on the above platforms. This is truly a pathfinding innovation.

Who will follow the Sasai Pathway created by Sasai.?

 A path is always created for people to thread on it or follow the path to a destination. For example, entrepreneurs created industries that many other entrepreneurs have used their system to build equally big businesses today. Consider the following industries;

1. Uber was fast followed by Lyft, Bolt, Vaya etc
2.  Microsoft was fast followed by many software companies including Codecitty.
3. Amazon was fast followed by Alibaba, eBay, Jumia, Wanabuy etc.
4. Facebook was fast followed by Twitter, Instagram, Linkedin etc.

 African entrepreneurs can fast follow the Sasai path in two ways;

1. By leveraging the existing technological infrastructures on the Sasai platform to build big businesses.
2. By learning from Sasai approach to solving other African problems.

Are you a pathfinder or an innovator? Don’t forget to download the 3S Rules free Sample and subscribe to receive weekly newsletter.

The fight against Coronavirus disease (COVID-19) seems to be getting to its end with humans claiming conquest. Two drugs that have been on trial appear to offer hope for a cure based on how patients respond to the treatment. Chloroquine phosphate is leading the way in offering recovery hope to victims according to trials conducted so far.

Chinese experts have confirmed based on clinical trial results, that chloroquine, an anti-malaria drug, surprisingly bears subduing effect on coronavirus. Chloroquine which has been in use for over 70 years now was selected among many other drugs tried on patients due to its promising effects.

Sun Yanrong, deputy head of the China National Center for Biotechnology Development under the Ministry of Science and Technology (MOST) said the progress recorded in the trials suggested that the drug will be included in the next version of the treatment guidelines and applied in wider clinical trials as soon as possible.

“In the trials, the groups of patients who were treated with chloroquine had better recovery rate compared to others who were placed on other drugs. In abatement of fever, improvement of CT images of lungs, the percentage of patients who became negative in viral nucleic acid tests and the time they need to do so, chloroquine showed better indicators,” she said.

Sun explained that the drug has been in clinical trials in over 10 hospitals in Beijing, as well as in South China’s Guangdong province and Central China’s Hunan province, and it showed the same efficient results.

On February 15, Zhong Nanshan, a respiratory specialist and a renowned figure of the Chinese academy of engineering, led a team of experts on a video conference. Prominent medical departments of health in china, including National Health Commission and the National Medical Products Administration deliberated on the effectiveness of various drugs on clinical trial and agreed to use chloroquine phosphate in treating COVID-19 patients.

Chloroquine blocks viral infections by increasing endosomal pH required for virus/cell fusion, it also interferes with the glycosylation of cellular receptors of SARS-CoV10. Nature’s time-of-addition assay showed that chloroquine functioned at both entry and post-entry stages of the 2019-nCoV infection in Vero E6 cells. Apart from its capacity to inhibit viral activities, chloroquine offers immune-modulating activity, which may synergistically enhance its antiviral activity in vivo. Chloroquine circulates widely in the whole body, touching the lungs, which makes it effective even after oral administration.

So far, two drugs have shown efficacy against COVID-19. Remdesivir has been as promising as it was in the past cases against a wide array of viral infections, including SARS and MERS and by extension, Ebola.

According to the scientific magazine Nature, Remdesivir is an adenosine analogue, which incorporates into nascent viral RNA chains and results in premature termination. The clinical time-of-addition assay showed remdesivir functioned at a stage post virus entry which agrees with its putative anti-viral mechanism as a nucleotide analogue.

The data collected from Nature showed that  EC90 value of remdesivir against 2019-nCoV in Vero E6 cells was 1.76  ?M, which suggests that its working concentration is likely to be achieved in NHP. The supplementary data also showed that Remdesivir inhibited virus infection efficiently in a human cell line (human liver cancer Huh-7 cells), which is sensitive to COVID-19.

Coronavirus has already killed over 2,004 people around the world, but mainly in China where the disease started in December last year. About 75,000 people have been infected so far as the disease keeps spreading across borders. The Chinese government has been cooperating with other governments around the world in search of a cure.

Hope seems to be lying within for long while scientists research for a possible cure. The major obstacle to finding a cure has been the inability of researchers to figure out the source of the disease. While there is yet to be an approved cure for the viral infection, the two drugs offer remedy.

The scientific discovery reveals that chloroquine and remdesivir are highly effective in the control of CODIV-19. They have been recommended for administration on patients suffering from coronavirus disease.